ATIP vs. ENZ, TOI, CCM, MRAI, BRTX, KDLY, ATPC, OTRK, OPGN, and MGRX
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Oncology Institute (TOI), Concord Medical Services (CCM), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Agape ATP (ATPC), Ontrak (OTRK), OpGen (OPGN), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry.
ATI Physical Therapy vs.
Enzo Biochem (NYSE:ENZ) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking.
36.9% of Enzo Biochem shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 11.4% of Enzo Biochem shares are held by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Enzo Biochem received 197 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 54.22% of users gave Enzo Biochem an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
Enzo Biochem has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500.
ATI Physical Therapy has a net margin of -7.79% compared to Enzo Biochem's net margin of -75.34%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.
In the previous week, Enzo Biochem had 7 more articles in the media than ATI Physical Therapy. MarketBeat recorded 8 mentions for Enzo Biochem and 1 mentions for ATI Physical Therapy. Enzo Biochem's average media sentiment score of 0.20 beat ATI Physical Therapy's score of 0.00 indicating that Enzo Biochem is being referred to more favorably in the media.
Enzo Biochem has higher earnings, but lower revenue than ATI Physical Therapy.
Summary
Enzo Biochem beats ATI Physical Therapy on 8 of the 13 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ATI Physical Therapy Competitors List
Related Companies and Tools
This page (NYSE:ATIP) was last updated on 1/21/2025 by MarketBeat.com Staff